ArticleEJHaem2025

Safe and Efficacious Use of Low-Dose Rituximab in Postpubertal Paediatric Patients With Immune Thrombocytopenia.

Jennifer Darlow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.